KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Treasury Shares (2018 - 2025)

Elanco Animal Health (ELAN) has disclosed Treasury Shares for 8 consecutive years, with $5.5 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 120.0% to $5.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.5 million through Dec 2025, up 120.0% year-over-year, with the annual reading at $5.5 million for FY2025, 120.0% up from the prior year.
  • Treasury Shares hit $5.5 million in Q4 2025 for Elanco Animal Health, up from $2.5 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $5.5 million in Q4 2025 to a low of $1.0 million in Q4 2021.
  • Historically, Treasury Shares has averaged $3.0 million across 5 years, with a median of $2.5 million in 2024.
  • Biggest five-year swings in Treasury Shares: tumbled 58.33% in 2021 and later surged 120.0% in 2025.
  • Year by year, Treasury Shares stood at $1.0 million in 2021, then surged by 100.0% to $2.0 million in 2022, then skyrocketed by 95.0% to $3.9 million in 2023, then crashed by 35.9% to $2.5 million in 2024, then skyrocketed by 120.0% to $5.5 million in 2025.
  • Business Quant data shows Treasury Shares for ELAN at $5.5 million in Q4 2025, $2.5 million in Q4 2024, and $3.9 million in Q4 2023.